D Enko1, G Kriegshäuser1, R Stolba1, H Mangge2, D Brandstetter3, N Mayr4, T Forstner5, G Halwachs-Baumann1. 1. Institute of Clinical Chemistry and Laboratory Medicine, General Hospital Steyr, Steyr, Austria. 2. Clinical Institute of Medical and Laboratory Diagnostics, Medical University of Graz, Graz, Austria. 3. University of Applied Sciences for Health Professions Upper Austria, Bachelor Programme Biomedical Science, General Hospital Steyr, Steyr, Austria. 4. University of Applied Sciences for Health Professions Upper Austria, Bachelor Programme Dietetics, General Hospital Elisabethinen Linz, Linz, Austria. 5. Department of Applied Systems Research and Statistics, Johannes Kepler University Linz, Linz, Austria.
Abstract
BACKGROUND/ OBJECTIVES: Primary adult-type lactose malabsorption (PALM) is a widespread inherited autosomal recessive condition, which is considered to be associated with osteoporosis. This prospective study aimed at assessing the 25-hydroxy-vitamin D (25(OH)D) status and serum CrossLaps levels in individuals with PALM and normal controls. SUBJECTS/ METHODS: All participants (n=210) underwent genotyping for the LCT C/T-13910 polymorphism, 25(OH)D and CrossLaps measurements and clinical examinations. In addition, the anthropometric data (that is, height, weight and body mass index) were determined. RESULTS: Fifty-five individuals with PALM (that is, LCT C/C-13910 homozygotes) showed lower 25(OH)D (mean: 24.95±10.04 vs 28.59±9.56 ng/ml, P=0.018) and higher CrossLaps serum levels (mean: 0.46±0.31 vs 0.43±0.49 ng/ml, P=0.251) compared with 155 normal controls (that is, LCT C/T-13910 hetero- or T/T-13910 homozygotes). Anthropometric data were similar between PALM probands and controls. CONCLUSIONS: Individuals with PALM were found to have lower 25(OH)D and higher CrossLaps serum levels compared with normal controls. In order to preserve life-long bone health, routine 25(OH)D and CrossLaps serum measurements should be performed in individuals with PALM.
BACKGROUND/ OBJECTIVES: Primary adult-type lactose malabsorption (PALM) is a widespread inherited autosomal recessive condition, which is considered to be associated with osteoporosis. This prospective study aimed at assessing the 25-hydroxy-vitamin D (25(OH)D) status and serum CrossLaps levels in individuals with PALM and normal controls. SUBJECTS/ METHODS: All participants (n=210) underwent genotyping for the LCT C/T-13910 polymorphism, 25(OH)D and CrossLaps measurements and clinical examinations. In addition, the anthropometric data (that is, height, weight and body mass index) were determined. RESULTS: Fifty-five individuals with PALM (that is, LCT C/C-13910 homozygotes) showed lower 25(OH)D (mean: 24.95±10.04 vs 28.59±9.56 ng/ml, P=0.018) and higher CrossLaps serum levels (mean: 0.46±0.31 vs 0.43±0.49 ng/ml, P=0.251) compared with 155 normal controls (that is, LCT C/T-13910 hetero- or T/T-13910 homozygotes). Anthropometric data were similar between PALM probands and controls. CONCLUSIONS: Individuals with PALM were found to have lower 25(OH)D and higher CrossLaps serum levels compared with normal controls. In order to preserve life-long bone health, routine 25(OH)D and CrossLaps serum measurements should be performed in individuals with PALM.
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Nabil Sabri Enattah; Timo Sahi; Erkki Savilahti; Joseph D Terwilliger; Leena Peltonen; Irma Järvelä Journal: Nat Genet Date: 2002-01-14 Impact factor: 38.330
Authors: K Bácsi; J P Kósa; A Lazáry; B Balla; H Horváth; A Kis; Z Nagy; I Takács; P Lakatos; G Speer Journal: Osteoporos Int Date: 2008-08-13 Impact factor: 4.507
Authors: Barbara M Obermayer-Pietsch; Christine M Bonelli; Daniela E Walter; Regina J Kuhn; Astrid Fahrleitner-Pammer; Andrea Berghold; Walter Goessler; Vinzenz Stepan; Harald Dobnig; Georg Leb; Wilfried Renner Journal: J Bone Miner Res Date: 2004-01 Impact factor: 6.741